mTOR Inhibitors in the Treatment of Breast Cancer

Efforts to identify clinical biomarkers of response or resistance to mTOR inhibitors are ongoing. This review will summarize results of preclinical and clinical studies as well as ongoing clinical trials with mTOR or dual PI3K/mTOR inhibitors.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news